AZ and GSK Dip Into Diagnostics To Support COVID-19 UK Tests

Also Lending Expertise In Automation And Robotics

The pharma giants are joining forces to help the UK reach its ambitious target of testing 100,000 people a day for coronavirus by the end of April.

Swabbed
Concerns grow over shortage of coronavirus testing • Source: Shutterstock

AstraZeneca PLC and GlaxoSmithKline PLC are diving into the unchartered waters of diagnostics to help the UK government's plans to boost testing for COVID-19.

The two pharmaceutical giants are linking up with the University of Cambridge and setting up a testing facility at the...

Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from COVID-19

More from Scrip